Comparison and process optimization of PLGA, chitosan and silica nanoparticles for potential oral vaccine delivery

被引:15
作者
Amin, Muhammad K. [1 ]
Boateng, Joshua S. [1 ]
机构
[1] Univ Greenwich, Fac Engn & Sci, Sch Sci, Medway ME4 4TB, Kent, England
关键词
bovine serum albumin; chitosan; nanoparticles; oral vaccination; poly(lactic-co-glycolic acid); process optimization; protein delivery; silica; MOLECULAR-WEIGHT CHITOSAN; DRUG-RELEASE; MUCOSAL; MICROPARTICLES; INSULIN;
D O I
10.4155/tde-2019-0038
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim: The study compared performance of nanoparticles prepared from synthetic organic, natural organic and inorganic materials as vaccine delivery platforms. Materials & methods: Various formulation (concentration, polymer/silica:surfactant ratio, solvent) and process parameters (homogenization speed and time, ultrasonication) affecting functional performance characteristics of poly(lactic-co-glycolic acid) (PLGA), chitosan and silica-based nanoparticles containing bovine serum albumin were investigated. Nanoparticles were characterized using dynamic light scattering, x-ray diffraction, scanning/transmission electron microscopy, Fourier transform infrared spectroscopy and in vitro protein release. Results: Critical formulation parameters were surfactant concentration (PLGA, silica) and polymer concentration (chitosan). Optimized nanoparticles were spherical in shape with narrow size distribution and size ranges of 100-300 nm (blank) and 150-400 nm (protein loaded). Protein encapsulation efficiency was 26-75% and released within 48 h in a sustained manner. Conclusion: Critical formulation and process parameters affected size of PLGA, chitosan and silica nanoparticles and protein encapsulation, while silica produced the smallest and most stable nanoparticles.
引用
收藏
页码:493 / 514
页数:22
相关论文
共 39 条
[1]   Chitosan-based delivery systems for protein therapeutics and antigens [J].
Amidi, Maryam ;
Mastrobattista, Enrico ;
Jiskoot, Wim ;
Hennink, Wim E. .
ADVANCED DRUG DELIVERY REVIEWS, 2010, 62 (01) :59-82
[2]  
[Anonymous], 2015, J. Basic Appl. Pharm. Sci., DOI [10.7324/JAPS.2015.50701, DOI 10.7324/JAPS.2015.50701]
[3]   Silica particles:: A novel drug-delivery system [J].
Barbé, C ;
Bartlett, J ;
Kong, LG ;
Finnie, K ;
Lin, HQ ;
Larkin, M ;
Calleja, S ;
Bush, A ;
Calleja, G .
ADVANCED MATERIALS, 2004, 16 (21) :1959-1966
[4]   Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: A technical note [J].
Bhumkar, Devika R. ;
Pokharkar, Varsha B. .
AAPS PHARMSCITECH, 2006, 7 (02)
[5]   Production of haloperidol-loaded PLGA nanoparticles for extended controlled drug release of haloperidol [J].
Budhian, A ;
Siegel, SJ ;
Winey, KI .
JOURNAL OF MICROENCAPSULATION, 2005, 22 (07) :773-785
[6]   Preparation, characterization and immunological evaluation: canine parvovirus synthetic peptide loaded PLGA nanoparticles [J].
Derman, Serap ;
Mustafaeva, Zeynep Akdeste ;
Abamor, Emrah Sefik ;
Bagirova, Melahat ;
Allahverdiyev, Adil .
JOURNAL OF BIOMEDICAL SCIENCE, 2015, 22
[7]   Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique [J].
Fan, Wen ;
Yan, Wei ;
Xu, Zushun ;
Ni, Hong .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2012, 90 :21-27
[8]   Optimization of protein encapsulation in PLGA nanoparticles [J].
Feczko, T. ;
Toth, J. ;
Dosa, Gy. ;
Gyenis, J. .
CHEMICAL ENGINEERING AND PROCESSING-PROCESS INTENSIFICATION, 2011, 50 (08) :757-765
[9]   Chitosan nanoparticle as protein delivery carrier - Systematic examination of fabrication conditions for efficient loading and release [J].
Gan, Quan ;
Wang, Tao .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2007, 59 (01) :24-34
[10]   Vaccine delivery using nanoparticles [J].
Gregory, Anthony E. ;
Titball, Richard ;
Williamson, Diane .
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2013, 3